Currently, the clinical diagnosis of PD is based on aforementioned typical motor symptoms and novel diagnostic biomarkers such as imaging markers, fluid and tissue α-synuclein markers have been developed (5). The gene discussed is SNCA; the disease is Parkinson disease.